Skip to content

Monark Criticare: India’s critical care Diclofenac Sodium Injection 75mg/ml

GMP conditionsBatch released
LIQUID INJECTABLEPhotograph on request
Analgesic

MICFLAM

Diclofenac Sodium Injection 75mg/ml

Packing
PresentationLiquid Injectable
  • Released against specification
  • Certificate of analysis enclosed
  • Liquid Injectable presentation
  • Pan-India dispatch
  • 300 injectables
  • 11 therapeutic groups
  • One distributor per district

Uses of MICFLAM

A non steroidal anti inflammatory given by injection for acute pain, sometimes combined with an antispasmodic where the pain is colicky in origin.

The class is effective and cheap, and its risks are well characterised: gastrointestinal, renal and cardiovascular. In a hospital population, and particularly in patients who are dehydrated or have any degree of renal impairment, those risks are the reason it is used at the lowest effective dose for the shortest time.

  • Acute moderate to severe pain, including postoperative pain
  • Renal and biliary colic, particularly the antispasmodic combinations
  • Acute musculoskeletal pain and inflammation
  • Fever unresponsive to other measures, as directed

Indication categories, not an exhaustive list, and not a recommendation for any individual patient.

Quality-driven manufacturing behind MICFLAM

96
Injectables in the live range
11
Therapeutic groups covered
4
Dosage forms manufactured
1
Distributor per district
Territory

PCD pharma franchise for MICFLAM, available across India

Enquiries accepted from every state and union territory. Whether a specific district is still open changes week to week, so it is answered by a person rather than by this page.

North8
  • Punjab
  • Haryana
  • Himachal Pradesh
  • Jammu & Kashmir
  • Uttarakhand
  • Delhi NCR
  • Rajasthan
  • Uttar Pradesh
West & Central5
  • Gujarat
  • Maharashtra
  • Goa
  • Madhya Pradesh
  • Chhattisgarh
South6
  • Karnataka
  • Kerala
  • Tamil Nadu
  • Andhra Pradesh
  • Telangana
  • Puducherry
East & North-East12
  • Bihar
  • Jharkhand
  • Odisha
  • West Bengal
  • Assam
  • Meghalaya
  • Tripura
  • Manipur
  • Nagaland
  • Mizoram
  • Arunachal Pradesh
  • Sikkim

Exclusive district rights — one distributor per district, named in the agreement.

Check my district
The comparison

Why Monark Criticare versus a typical supplier?

Every row is a term stated elsewhere on this site and held to in writing. Nothing here is a claim about a certificate we have not seen.

Factor
Monark Criticare
Typical supplier
Territory
One distributor per district, named in the agreement
Shared, rarely written down
Rate list
Net rates, pack sizes and MRP issued up front
On request, after commitment
First orders
No minimum on the first two order cycles
High minimum from the start
Batch paperwork
Certificate of analysis travels in the consignment
Emailed later, if chased
Manufacturing
GMP conditions, every batch released against specification
Varies by site
Range depth
96 injectables across 11 therapeutic groups
Thin outside the fast movers
Dispatch
Pan-India from one site, cold chain where the molecule needs it
Multi-site, variable
Reply time
Usually inside one working day
Days, or not at all
Territory
Monark CriticareOne distributor per district, named in the agreement
Typical supplierShared, rarely written down
Rate list
Monark CriticareNet rates, pack sizes and MRP issued up front
Typical supplierOn request, after commitment
First orders
Monark CriticareNo minimum on the first two order cycles
Typical supplierHigh minimum from the start
Batch paperwork
Monark CriticareCertificate of analysis travels in the consignment
Typical supplierEmailed later, if chased
Manufacturing
Monark CriticareGMP conditions, every batch released against specification
Typical supplierVaries by site
Range depth
Monark Criticare96 injectables across 11 therapeutic groups
Typical supplierThin outside the fast movers
Dispatch
Monark CriticarePan-India from one site, cold chain where the molecule needs it
Typical supplierMulti-site, variable
Reply time
Monark CriticareUsually inside one working day
Typical supplierDays, or not at all

Start your critical care business with MICFLAM take the district before it is allocated

Send the districts you cover and the segments you already sell into. You get the rate list, the pack sizes and a straight answer on availability, usually inside one working day.

Get franchise quote

Get franchise quote for MICFLAM

Interested in Diclofenac Sodium Injection 75mg/ml for your pharma franchise business? Fill the form and we come back with the rate list, the pack sizes and district availability.

  • Exclusive district rights, recorded in the agreement
  • Net rates, pack sizes and MRP issued before you commit
  • No minimum on the first two order cycles
  • Batch documentation and certificate of analysis with every consignment

Send enquiry

Fill in your details and we will contact you shortly.

MICFLAM  |  Diclofenac Sodium Injection 75mg/ml

This website is a business to business platform intended for pharmaceutical traders, distributors, wholesalers, hospitals and healthcare professionals. Product compositions, therapeutic categories and portfolio information are published for commercial and educational reference only.

Nothing here is medical advice, a prescribing recommendation or a substitute for professional diagnosis or treatment. We do not sell medicines directly to individuals, and all trade enquiries are subject to verification of a valid drug licence before any supply is agreed.

The details you send are used to answer this enquiry and to contact you about it, by phone, WhatsApp or email. They are not sold and not passed to anyone outside this company.

Read the full privacy policy

Tick the box above to enable this button

Or call us: +91 90567 60548 | +91 98886 56719

Related products

View all products →